Microfluidic Chip for 3D Breast Tumor Microenvironment Modeling

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current models for studying cancer metastasis lack physiologically relevant in vitro microenvironments to effectively investigate the metastatic behavior of cancer cells in response to biophysical and biochemical stimuli, limiting the development of therapeutic strategies for breast cancer.

Innovation Solution

A microfluidic device is developed using hydrogel-based biomaterials and microengineering technology to create a 3D vascularized human breast tumor microenvironment, incorporating cancer cells, stromal cells, and endothelial cells, allowing for precise control of cellular interactions and microenvironmental conditions, thereby recapitulating the complexities of the native tumor stroma.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If 2D rigid substrates and Boyden chambers are used for in vitro cell migration studies, then high throughput and economic efficiency are achieved, but the physiological relevance and complexity of the tumor microenvironment are lost

Engineering Contradiction:

Improvehigh throughputVSAvoidphysiological relevance

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent transitions from 2D rigid substrates to 3D hydrogel matrices, adding a spatial dimension that better replicates the extracellular matrix environment. This dimensional change allows cells to migrate through a three-dimensional space with appropriate mechanical properties, thereby improving physiological relevance while maintaining the in vitro high-throughput capability

Inventive Principle:

Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The invention uses composite hydrogel materials that combine multiple ECM components (collagen, fibronectin, laminin) to create a multifunctional matrix. This composite approach provides both structural support and biochemical signaling capabilities, enabling high-throughput screening while preserving the complexity of the native tumor microenvironment

Inventive Principle:

Principle #40Composite materials

2Reliability

If 3D macroscale ECM hydrogels are used to study cancer biology, then drug resistance profiles similar to in vivo models are achieved, but precise control over cellular distribution and vascularity is lost

Engineering Contradiction:

Improvedrug resistance profilesVSAvoidprecise control over cellular distribution

Core Design Contradiction:

ReliabilityVSEase of operation

Solution Approach 1:

The patent replaces manual or mechanical cell distribution methods with microfluidic-based automated injection systems. These systems use controlled fluid flow to deliver cells and growth factors to precise locations within the hydrogel matrix, enabling accurate spatial control while maintaining the 3D architecture necessary for realistic drug resistance profiles

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention introduces microfluidic channels as intermediary structures that facilitate controlled delivery of cells, nutrients, and therapeutic agents through the hydrogel matrix. These channels act as conduits that enable precise spatial control over cellular distribution and create defined vascular-like structures for systematic drug delivery

Inventive Principle:

Principle #24Intermediary (Mediator)

3Device complexity

If simplified models with limited microenvironmental cues are used, then device complexity is reduced, but the physiological relevance of the tumor microenvironment is compromised

Engineering Contradiction:

Improvemodel simplicityVSAvoidphysiological relevance

Core Design Contradiction:

Device complexityVSReliability

Solution Approach 1:

The patent divides the tumor microenvironment into distinct functional zones within the hydrogel matrix, including tumor cell regions, stromal cell regions, and vascular channels. This segmentation allows each zone to be optimized for its specific function while maintaining overall system simplicity through modular design and standardized microfluidic components

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The invention implements local quality by providing different biochemical and mechanical properties in different regions of the hydrogel matrix. For example, tumor regions may have higher cell density and different ECM composition compared to stromal regions, creating locally optimized environments that collectively reproduce the complexity of the native tumor microenvironment without requiring uniform complexity throughout

Inventive Principle:

Principle #3Local quality

Data Source

PatentUS10017724B2Engineering of a novel breast tumor microenvironment on a microfluidic chip

Publication Date: 2018.07.10 MASSACHUSETTS INST OF TECH

AI summary

A microfluidic device for more accurately modeling the in vitro environment in which cancer occurs is disclosed. The device comprises a surface defining one or more microfluidic channels that may further comprise one or more endothelial cells, a first three dimensional scaffold comprising one or more cancer cells that is spatially separated from the one or more microfluidic channels, and a second three dimensional scaffold comprising one or more stromal cells, at least a portion of which is interposed between the one or more microfluidic channels and the first three dimensional scaffold. The second three dimensional scaffold is in fluid communication with both the first three dimensional scaffold and the one or more microfluidic channels. The device can be used to assay anti-cancer agents, or as a system for modeling the growth, behavior, or metastasis and tumor formation of cancer cells.